Fig. 6From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathwayThe activation of EMT and Wnt/β-catenin signaling pathway by miR-1825 downregulation. a Decreased expression of E-cadherin expression, but increased N-cadherin and vimentin expression by miR-1825 mimic. Increased E-cadherin expression, but decreased N-cadherin and vimentin expression by miR-1825 inhibitor. b Reduced β-catenin, c-myc, and p-c-Jun expression by miR-1825 mimic and increased expression of β-catenin, c-myc, and p-c-Jun expression by miR-1825 inhibitorBack to article page